P erinatal hypoxia-ischemia (HI) is a significant cause of neonatal brain injury. Neonatal animal models of HI show that excessive production of nitric oxide (NO), mediated by nitric oxide synthases (NOS), play an important role in the pathogenesis of neuronal injury after HI in the neonate.1,2 Three isoforms of NOS exist: the constitutively expressed neuronal NOS, endothelial NOS, and the inducible NOS. In vitro studies have shown that selective inhibition of neuronal NOS and inducible NOS can be achieved by the NOS inhibitor 2-iminobiotin (2-IB).
3To transition treatment to the human term neonate, it is important to know the dose-response effect of 2-IB to identify the optimal dose to be given after perinatal HI. The aim of this study was to determine the dose-response characteristics of 2-IB in a preclinical animal model of perinatal HI and to establish the most effective dose (range) for future clinical trials. This study was performed in our piglet model of inhalational HI, which is clinically, electrophysiologically, and neuropathologically comparable with the term born human neonate. The HI insult was performed in term neonatal piglets (n=47) as previously described 5 ; 6 animals served as sham-operated controls. HI piglets were randomly assigned to blinded treatment with vehicle or 2-IB at 0.1, 0.2, or 1 mg/kg/dose i.v. immediately post-HI and dosing repeated every 4 h until 20 h (6 doses in total). aEEG background pattern, presence of epileptic activity, and neurobehavior were scored.
6At 48 h postinsult animals were euthanized and tissue analyzed for caspase-3 activity, tyrosine nitration, and histology (see the onlineonly Data Supplement).
ResultsIn total, 47 piglets were subjected to HI; 16 piglets were only mildly affected (continuous normal voltage at 30 min post-HI; see the online-only Data Supplement for examples) and excluded from further analysis. Of the remaining 31 piglets, 10 were vehicle-treated, 7 received 0.1 mg/kg/dose, 9 received 0.2 mg/kg/dose, and 5 received 1.0 mg/kg/dose. There was no difference in birth weight, postnatal age, pH, arterial BE, PO 2 , PCO 2, duration of hypotension, heart rate, or temperature between treatment groups (see the online-only Data Supplement).Background and Purpose-To determine the optimal dose of 2-iminobiotin (2-IB) for the treatment of moderate to severe asphyxia in a neonatal piglet model of hypoxia-ischemia. Methods-Newborn piglets were subjected to a 30-minute hypoxia-ischemia insult and randomly treated with vehicle or 2-IB (0.1 mg/kg, 0.2 mg/kg, or 1.0 mg/kg). aEEG background and seizure activity were scored after hypoxia-ischemia every 4 h until 24 h and at 48 h and neurobehavioral scores were obtained. Brain tissue was collected and processed for analysis of caspase-3 activity, histology, and tyrosine nitration. Results-A dose range of 0.1 to 1.0 mg/kg/dose of 2-IB improved short-term outcome as demonstrated by an increased survival with a normal aEEG and decreased nitrotyrosine staining in the 2-IB-treated animals, indicating decreased cellular...